Protagenic Therapeutics Overview
Latest PEG ratio for Protagenic Therapeutics: -0.34 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-0.34
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for PTIX is -0.34. That is below the Industrials sector average of 16.95. Investors often review this figure alongside Protagenic Therapeutics's historical trend and sector peers before judging valuation or financial health.
Against Industrials companies, PTIX currently prints -0.34 for PEG ratio, while the sector average sits near 16.95. That is roughly 102.0% below the sector mean. Large gaps often invite a closer look at Protagenic Therapeutics's growth, margins, and balance sheet.
A PEG ratio of -0.34 for Protagenic Therapeutics is not 'good' or 'bad' on its own. Compare it with the peer average (16.95) and with PTIX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting PTIX's PEG ratio (-0.34), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Protagenic Therapeutics's PEG ratio against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.
